🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +11.97% on $543A.T in just 96h 1m.
EW
$EW
🔒 US EquitiesEdwards Lifesciences Corporatio
AVG HISTORICAL GAP
-1.66%
MAX GAP RECORD
-26.38%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $EW
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$EW
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Jul 23, 2026 Earnings Release 2026-07-23 (AFTER CLOSE) |
+4.99%
|
| Apr 22, 2026 Earnings Release 2026-04-22 (AFTER CLOSE) |
+0.00%
|
| Feb 10, 2026 Earnings Release 2026-02-10 (AFTER CLOSE) |
+2.02%
|
| Oct 30, 2025 Earnings Release 2025-10-30 (AFTER CLOSE) |
+1.20%
|
| Jul 29, 2025 Earnings Release 2025-07-29 (BEFORE OPEN) |
+1.27%
|
| Apr 28, 2025 Earnings Release 2025-04-28 (BEFORE OPEN) |
+1.73%
|
| Jan 29, 2025 Earnings Release 2025-01-29 (AFTER CLOSE) |
+2.78%
|
| Oct 30, 2024 Earnings Release 2024-10-30 (BEFORE OPEN) |
-1.23%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.1%
Bullish Gaps (8)
Bearish Gaps (5)
Neutral / Flat (0)
📖 Intelligence Summary
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗